Benefits
NAFLD/MASLD support — strongest evidence
2021 systematic review and meta-analysis of 7 RCTs (8 treatment arms) — Chlorella vulgaris significantly reduced AST (WMD -9.15 U/L, 95% CI -16.09 to -2.21) in NAFLD patients. 2026 grade-assessed systematic review (7 RCTs, 375 patients) confirmed effects on liver enzymes, lipids, metabolic markers. Panahi RCT (n=76, 1,200 mg/day × 3 months) — chlorella + metformin reduced ALT, AST, triglycerides, HbA1c, HOMA-IR. Caveat: most trials in Iran, modest sample sizes.
Heavy metal 'detox' — popular claim, weak human evidence
Honest framing: human RCT evidence is weak. Uchikawa 2010-2011 (, 21297350) showed 1.9-2.2× increased mercury excretion in mice — funded by Chlorella Industry Co. Ltd. Maruyama 2018 — open-label (not placebo-controlled) trial in 58 healthy volunteers, 9 g/day × 3 months, decreased hair/blood mercury. No rigorous placebo-controlled human RCTs. The 'chlorella detoxes heavy metals' marketing far exceeds the actual evidence quality.
Lipid and glucose modulation in metabolic syndrome
Multiple small RCTs show chlorella reduces total cholesterol, LDL, triglycerides, and improves fasting glucose in adults with metabolic syndrome and T2D. Effect sizes modest. Mechanism: combination of fiber-mediated cholesterol absorption reduction, antioxidant effects, and possible GLP-1 modulation. Reasonable adjunct to dietary intervention; not a substitute for established lipid-lowering or glucose-lowering medications.
Immune function — preliminary evidence
Small RCTs suggest CGF-rich chlorella supplementation enhances NK cell activity and antibody response to influenza vaccination. Otsuki 2011 — CGF-rich chlorella improved IgA secretion in adults. Effects modest in small trials; not validated for immune-related disease prevention or treatment. Plausible mechanism via β-glucans, CGF, and nucleotide content.
Nutritional density — legitimate whole-food benefits
Chlorella provides complete protein (all essential amino acids, ~60% by dry weight), B-complex vitamins (including B12 — though bioavailability of plant-source B12 is debated), iron, magnesium, and zinc. Useful as a nutrient-dense supplement for vegans/vegetarians or those seeking concentrated whole-food nutrition. This nutritional contribution is real and uncontroversial — distinct from the more speculative 'detox' claims.
B12 from chlorella — bioavailability debated
Chlorella contains vitamin B12, but research suggests much of it is in 'pseudo-B12' forms (analogs that don't have full bioactivity). Some recent trials show chlorella raises serum B12 in vegan/vegetarian adults, but effect varies by strain and processing. Honest framing: not a reliable B12 source for those who need supplementation; methylcobalamin or cyanocobalamin remain first-line for B12 deficiency.
Cell wall processing matters
Chlorella's tough cell wall must be cracked or broken for nutrient bioavailability. Whole intact cells pass through GI tract largely undigested. Quality products specify cracked/broken cell wall processing. Spray-dried versus mechanically processed forms vary in bioavailability. Critical product-quality factor — generic 'chlorella powder' without processing specification may be poorly bioavailable.
Heavy metal contamination risk — real concern
Ironic but important: chlorella itself can accumulate heavy metals from its growth water. Some products have been found contaminated with arsenic, lead, mercury, or cadmium — the very substances chlorella is marketed to remove. Choose products with third-party heavy metal testing (USP, ConsumerLab, or NSF certification). Tank-grown vs open-pond chlorella has different contamination profiles. Source transparency matters substantially.
Mechanism of action
Cell wall binding and gut-level adsorption
Chlorella cell walls contain sporopollenin and complex polysaccharides that can adsorb organic compounds and metals at the gut level. Mechanism is real but limited to enterohepatic circulation — chlorella does not chelate metals from systemic tissues. The 'gut-level binding' mechanism is the most defensible part of the detox claim, but still requires more rigorous human trials.
Chlorella Growth Factor (CGF) immune modulation
CGF is a nucleotide/peptide/polysaccharide complex unique to chlorella. Stimulates NK cell activity, macrophage function, and IgA production in some studies. Mechanism plausible but clinical effect sizes modest. Often cited as the basis for immune marketing claims.
Antioxidant and anti-inflammatory pathways
Chlorella contains chlorophyll, carotenoids, and tocopherols providing antioxidant capacity. Modest reductions in inflammatory markers (CRP, TNF-α) in some small RCTs. May support glutathione synthesis through sulfur-containing amino acid contribution.
Fiber-mediated lipid effects
Chlorella's cell wall fiber content may bind bile acids and reduce cholesterol absorption similarly to other dietary fibers. Mechanism for the modest LDL-lowering effects observed in metabolic syndrome trials. Comparable in effect size to typical dietary fiber interventions, not pharmaceutical lipid-lowering.
Whole-food micronutrient delivery
Most uncontroversial chlorella mechanism: provides complete protein, B vitamins, iron, magnesium, and zinc in food-matrix form. Useful for vegans/vegetarians or those with limited dietary diversity. This is straightforward nutritional science, distinct from the more speculative functional claims.
Clinical trials
Evidence review and pooled analysis of 7 clinical trials (8 treatment arms) of Chlorella vulgaris in NAFLD patients.
7 clinical trials pooled
Evidence review and pooled analysis of 7 clinical trials (8 treatment arms) of Chlorella vulgaris in NAFLD patients. Significant AST reduction: WMD -9.15 U/L (95% CI -16.09 to -2.21). Improvements in liver enzymes and lipid profiles. Most-rigorous evidence base for chlorella supplementation. Caveat: most included trials conducted in Iran with modest sample sizes.
Clinical trial in 76 NAFLD patients with type 2 diabetes.
Clinical population described in trial publication.
Clinical trial in 76 NAFLD patients with type 2 diabetes. Chlorella vulgaris 1,200 mg/day × 3 months as adjunct to metformin vs metformin alone. Reductions in ALT, AST, triglycerides, HbA1c, and HOMA-IR. Reasonable evidence for chlorella as metabolic adjunct in NAFLD with diabetes. Not a substitute for first-line pharmacotherapy.
Mouse studies (not human) by Uchikawa et al.
Clinical population described in trial publication.
Mouse studies (not human) by Uchikawa et al. funded by Chlorella Industry Co. Ltd (manufacturer). (2010): Chlorella increased fecal/urinary mercury excretion 1.9-2.2× in MeHg-exposed mice. (2011): Lowered tissue mercury levels with 5-10% chlorella in diet. Animal evidence for the marketing claim — not human evidence. Industry funding is relevant context.
Open-label naturalistic trial (not placebo-controlled) in 58 healthy volunteers (35 chlorella, 23 control). 9 g/day × 3 months.
Clinical population described in trial publication.
Open-label naturalistic trial (not placebo-controlled) in 58 healthy volunteers (35 chlorella, 23 control). 9 g/day × 3 months. Decreased hair and blood mercury concentrations. Limitations: open-label design, no placebo, healthy volunteers (not heavy-metal-exposed populations). Often cited but methodologically weak — no rigorous placebo-controlled clinical trials have replicated.
Small clinical trial in adults — CGF-rich chlorella supplementation enhanced salivary IgA secretion.
Clinical population described in trial publication.
Small clinical trial in adults — CGF-rich chlorella supplementation enhanced salivary IgA secretion. Other small trials suggest improved NK cell activity and antibody response to influenza vaccination. Effects modest; preliminary evidence base. Not validated for immune-related disease prevention.